Posted on 18 February 2015
Tags: big pharma, dealtalk, M&A, Novartis, Pfizer
India-based CLARIS Lifesciences Ltd., which operates a generic sterile injectables business, has become the belle of the ball as multi-national companies such as Pfizer Inc., Amneal, Novartis AG and Indian companies such as Lupin and Cipla, are lining up to play the Read the full story
Posted on 17 February 2015
Tags: big pharma, dealtalk, Novartis, pharma deals
Novartis , the world's biggest pharmaceutical (big pharma) company, recently increased its interest in Israel to sign pharma deals. For a long time, the company was active in marketing and clinical trials in Israel, and now it is involved in investment as well. Read the full story
Posted on 16 February 2015
Tags: dealtalk, M&A, salix, shire, Valeant
M&A news: The Canadian pharma company Valeant Pharmaceuticals is rumoured to be raising money to make a bid for specialty drugmaker Salix Pharmaceuticals, according to Bloomberg, which cites people familiar with the matter.
Read the full story
Posted on 08 December 2014
Tags: big pharma, dealtalk, M&A
Biotech rumor mill: Helix BioPharma Corp. announced Friday that it has begun “a comprehensive exploration of growth opportunities,” code that most of the biotech market has taken to mean the company has a shopping list of potential acquisitions and will be buying snap-on targets soon. Read the full story
Posted on 31 October 2014
Tags: Bayer, big pharma, dealtalk, pharma deals
Big pharma company Bayer , is going hunting for pharma deals again, with its chief executive expected to tell media outlets that it is looking for further takeover pharma deals. Read the full story
Posted on 06 October 2014
Tags: acquisition, asset purchase, dealtalk, M&A
Arbor Pharmaceuticals LLC is allegedly exploring a potential acquisition and merger partner that could bring in more than $1 billion, according to people who are close to the situation.
Read the full story
Posted on 24 September 2014
Tags: acquisition, dealtalk, M&A
Pfizer Inc. has approached Actavis with a possibility to acquire the company. Read the full story
Posted on 15 September 2014
Tags: acquisition, dealtalk, M&A
Akorn targets UCB's subsidiary for acquisition for tax inversion. Read the full story
Posted on 02 September 2014
Tags: best practice, clinical, dealtalk, partnering, partnering agreements, partnering terms
Partnering trends for the top pharma and biotech companies reviewed with over 2,000 deals analyzed – including summary biopharma deal financials Read the full story